BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20019578)

  • 1. Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy.
    Chua TC; Baker B; Yan TD; Zhao J; Morris DL
    Am J Clin Oncol; 2010 Dec; 33(6):568-71. PubMed ID: 20019578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.
    Kluger MD; Taub RN; Hesdorffer M; Jin Z; Chabot JA
    Eur J Surg Oncol; 2010 Oct; 36(10):997-1003. PubMed ID: 20674253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study.
    Chua TC; Morris DL; Saxena A; Esquivel J; Liauw W; Doerfer J; Germer CT; Kerscher AG; Pelz JO
    Ann Surg Oncol; 2011 Jun; 18(6):1560-7. PubMed ID: 21203904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients.
    Bakrin N; Gilly FN; Baratti D; Bereder JM; Quenet F; Lorimier G; Mohamed F; Elias D; Glehen O;
    Eur J Surg Oncol; 2013 Jul; 39(7):742-7. PubMed ID: 23510853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
    Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
    Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of peritoneal surface malignancy of colorectal cancer origin.
    Tentes AA
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s39-42. PubMed ID: 15655638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreduction and intraperitoneal chemotherapy for the management of non-gynecological peritoneal surface malignancy.
    Yan TD; Esquivel J; Carmignani P; Sugarbaker PH
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):109-17. PubMed ID: 16767916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Verwaal VJ; van Tinteren H; van Ruth S; Zoetmulder FA
    Br J Surg; 2004 Jun; 91(6):739-46. PubMed ID: 15164445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience.
    Esquivel J; Averbach A; Chua TC
    Ann Surg; 2011 Apr; 253(4):764-8. PubMed ID: 21475017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy.
    Glehen O; Mohamed F; Sugarbaker PH
    Ann Surg; 2004 Aug; 240(2):278-85. PubMed ID: 15273552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer.
    Carmignani CP; Sugarbaker PH
    Eur J Surg Oncol; 2004 Oct; 30(8):864-8. PubMed ID: 15336733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate.
    Chua TC; Liauw W; Zhao J; Morris DL
    Ann Surg; 2011 Apr; 253(4):769-73. PubMed ID: 21475018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
    Schomas DA; Miller RC; Donohue JH; Gill S; Thurmes PJ; Haddock MG; Quevedo JF; Gunderson LL
    Ann Surg; 2009 Apr; 249(4):588-95. PubMed ID: 19300231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective therapy for peritoneal dissemination in gastric cancer.
    Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Endou Y; Sasaki T
    Surg Oncol Clin N Am; 2003 Jul; 12(3):635-48. PubMed ID: 14567022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome.
    Verwaal VJ; Boot H; Aleman BM; van Tinteren H; Zoetmulder FA
    Ann Surg Oncol; 2004 Apr; 11(4):375-9. PubMed ID: 15070596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of peritoneal carcinomatosis of non-gynecological origin].
    Bagnenko SF; Rukhliada NV; Grinev MV; Beliaev AM
    Vestn Khir Im I I Grek; 2002; 161(6):94-9. PubMed ID: 12638508
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival.
    Yan TD; Chu F; Links M; Kam PC; Glenn D; Morris DL
    Eur J Surg Oncol; 2006 Dec; 32(10):1119-24. PubMed ID: 16887321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.